The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer (BioSpace News, 11 January 2010)
A partnership formed between the Institut Curie and Ipsogen could lead to a better understanding of the diagnosis and personalised treatment of breast cancers, as the Institut shares its library of breast tumours to help evaluate Ipsogen's HER2 and HR genetic tests.Full article